In a deal worth approximately $50 million, GlaxoSmithKline has entered into an agreement to sell its West Campus in Upper Merion to O’Neill Properties Group.

The sale means that GSK employees working out of the west campus will be moved to the pharmaceutical company’s other local facilities, writes Natalie Kostelni at bizjournals.com.

[uam_ad id=”54865″]

“GSK will continue to occupy the Upper Merion West Campus after the transaction closes, and will be relocating a majority of employees to either Upper Providence or Upper Merion East over the next year,” GSK spokeswoman Frances DeFranco said.

The company will also keep its sterile manufacturing facility on the Upper Merion West Campus to support early phase development and clinical sterile drug product manufacturing, DeFranco said.

To read the complete story, click here.

[uam_ad id=”54875″]